LATISSE® 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. In 2008, LATISSE® became the first prescription product FDA approved to grow eyelashes—fuller, longer, and darker—in patients with eyelash hypotrichosis.

Increase length and darkness and more than double lash fullness in 16 weeks.

Recently Viewed Products